Blockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells.
暂无分享,去创建一个
Gerardo Botti | Gennaro Ciliberto | Maria Rosaria Giovagnoli | Gerry Melino | Enrico Giarnieri | Rita Mancini | R. Mancini | M. Pisanu | G. Botti | G. Ciliberto | M. Giovagnoli | I. Amelio | G. Melino | F. Venuta | D. Diso | G. Scognamiglio | F. Padula | M. Agostini | A. Ricci | A. Noto | S. Morrone | Federico Venuta | Fabrizio Padula | Massimiliano Agostini | Stefania Morrone | Maria Elena Pisanu | Alessia Noto | Claudia De Vitis | Giosuè Scognamiglio | Daniele Diso | Ziga Jakopin | Alberto Ricci | Salvatore Mariotta | Ivano Amelio | S. Mariotta | Ž. Jakopin | E. Giarnieri | C. de Vitis
[1] Anna Tesei,et al. Specific Biomarkers Are Associated with Docetaxeland Gemcitabine-Resistant NSCLC Cell Lines. , 2012, Translational oncology.
[2] Yu Xia,et al. Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells. , 2017, Cell stem cell.
[3] Liang Liu,et al. SCD1 is associated with tumor promotion, late stage and poor survival in lung adenocarcinoma , 2016, Oncotarget.
[4] J. Um,et al. Beneficial effect of dietary Ephedra sinica on obesity and glucose intolerance in high-fat diet-fed mice. , 2012, Experimental and therapeutic medicine.
[5] A. Sanz,et al. J Am Soc Nephrol 15: 380–389, 2004 Paracetamol-Induced Renal Tubular Injury: A Role for ER Stress , 2022 .
[6] Yushui Ma,et al. The role of cancer stem cells in cancer metastasis: new perspective and progress. , 2013, Cancer epidemiology.
[7] Y. Rino,et al. Prognostic value of CD133 expression in stage I lung adenocarcinomas. , 2010, International journal of clinical and experimental pathology.
[8] R. Mancini,et al. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ , 2017, Oncogene.
[9] A. Składanowski,et al. H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy , 2010, Journal of nucleic acids.
[10] R. Addeo. A new frontier for targeted therapy in NSCLC: clinical efficacy of pembrolizumab in the inhibition of programmed cell death 1 (PD-1) , 2017, Expert review of anticancer therapy.
[11] Yan-Ze Jin,et al. Prognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinoma , 2016, Oncotarget.
[12] Charles A Powell,et al. Non-small-cell lung cancer molecular signatures recapitulate lung developmental pathways. , 2003, The American journal of pathology.
[13] S. Thibodeau,et al. Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. , 2005, Chest.
[14] Alexander Roesch,et al. A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth , 2010, Cell.
[15] R. Mancini,et al. Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity , 2016, Journal of Translational Medicine.
[16] M. Huang,et al. Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling. , 2013, Cancer research.
[17] D. Gewirtz. The four faces of autophagy: implications for cancer therapy. , 2014, Cancer research.
[18] T. Oyama,et al. The Clinical Significance of Cancer Stem Cell Markers ALDH1A1 and CD133 in Lung Adenocarcinoma. , 2017, Anticancer research.
[19] M. Bonini,et al. Inhibition of StearoylCoA Desaturase-1 Inactivates Acetyl-CoA Carboxylase and Impairs Proliferation in Cancer Cells: Role of AMPK , 2009, PloS one.
[20] R. Mancini,et al. Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells , 2013, Cell Death and Disease.
[21] Yi Zhang,et al. Combined anticancer activity of osthole and cisplatin in NCI-H460 lung cancer cells in vitro , 2013, Experimental and therapeutic medicine.
[22] R. Mancini,et al. Synergistic antitumor activity of histone deacetylase inhibitors and anti-ErbB3 antibody in NSCLC primary cultures via modulation of ErbB receptors expression , 2016, Oncotarget.
[23] P. Zoppoli,et al. Spheres Derived from Lung Adenocarcinoma Pleural Effusions: Molecular Characterization and Tumor Engraftment , 2011, PloS one.
[24] A. Harris,et al. Inhibition of fatty acid desaturation is detrimental to cancer cell survival in metabolically compromised environments , 2016, Cancer & Metabolism.
[25] R A Knight,et al. DRUGSURV: a resource for repositioning of approved and experimental drugs in oncology based on patient survival information , 2014, Cell Death and Disease.
[26] Kenji Eguchi,et al. A Japanese Lung Cancer Registry Study: Prognosis of 13,010 Resected Lung Cancers , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[27] S. Krauss,et al. Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma , 2009, Clinical & Experimental Metastasis.
[28] T. Barrette,et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. , 2004, Neoplasia.
[29] Keunchil Park,et al. Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial , 2016, The Lancet.
[30] U. Rapp,et al. Oncogene-induced plasticity and cancer stem cells , 2008, Cell cycle.
[31] K. O'Byrne,et al. Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature , 2013, PloS one.
[32] A. Sytkowski,et al. Novel Interaction between the Transcription Factor CHOP (GADD153) and the Ribosomal Protein FTE/S3a Modulates Erythropoiesis* , 2000, The Journal of Biological Chemistry.
[33] S. Ou,et al. Prognostic factors for survival of stage I nonsmall cell lung cancer patients , 2007, Cancer.
[34] I. Petersen,et al. CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients , 2003, British Journal of Cancer.
[35] S. Matsuda,et al. Decrease in Membrane Phospholipid Unsaturation Induces Unfolded Protein Response* , 2010, The Journal of Biological Chemistry.
[36] Irving L Weissman,et al. Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. , 2006, Cancer research.
[37] J. Copland,et al. Stearoyl-CoA Desaturase 1 Is a Novel Molecular Therapeutic Target for Clear Cell Renal Cell Carcinoma , 2013, Clinical Cancer Research.
[38] R. Mancini,et al. Lung Cancer Stem Cell Lose Their Stemness Default State after Exposure to Microgravity , 2014, BioMed research international.
[39] S. Lyle,et al. Quiescent, Slow-Cycling Stem Cell Populations in Cancer: A Review of the Evidence and Discussion of Significance , 2010, Journal of oncology.
[40] J. Fargnoli,et al. Cancer Cell Dependence on Unsaturated Fatty Acids Implicates Stearoyl-CoA Desaturase as a Target for Cancer Therapy , 2011, Molecular Cancer Research.
[41] Min Wu,et al. Respiratory stem cells and progenitors: overview, derivation, differentiation, carcinogenesis, regeneration and therapeutic application. , 2006, Current stem cell research & therapy.
[42] A. Abarrategi,et al. Cancer stem cells and cisplatin-resistant cells isolated from non-small-lung cancer cell lines constitute related cell populations , 2014, Cancer medicine.
[43] Binsheng Zhao,et al. Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. , 2000, Radiology.
[44] Li-nian Huang,et al. Prognosis value of HIF-1α expression in patients with non-small cell lung cancer. , 2014, Gene.
[45] W. Lam,et al. Acquired resistance to EGFR inhibitors is associated with a manifestation of stem cell-like properties in cancer cells. , 2013, Cancer research.
[46] M. Edelman,et al. Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy , 2013, Clinical Cancer Research.
[47] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[48] F. Bertucci,et al. miR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT Signaling. , 2017, Cell reports.
[49] I. Amelio,et al. SynTarget: an online tool to test the synergetic effect of genes on survival outcome in cancer , 2016, Cell Death and Differentiation.
[50] Alexey V. Antonov,et al. BioProfiling.de: analytical web portal for high-throughput cell biology , 2011, Nucleic Acids Res..
[51] Guido Kroemer,et al. Self-eating and self-killing: crosstalk between autophagy and apoptosis , 2007, Nature Reviews Molecular Cell Biology.
[52] J. Copland,et al. Aberrant lipid metabolism in anaplastic thyroid carcinoma reveals stearoyl CoA desaturase 1 as a novel therapeutic target. , 2015, The Journal of clinical endocrinology and metabolism.
[53] C. Lee,et al. CD24, a Novel Cancer Biomarker, Predicting Disease-Free Survival of Non-small Cell Lung Carcinomas: A Retrospective Study of Prognostic Factor Analysis from the Viewpoint of Forthcoming (Seventh) New TNM Classification , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[54] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[55] S. Farber,et al. A practical diagnostic method in lung‐cancer detection , 1952 .
[56] Funda Meric-Bernstam,et al. High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients , 2012, Breast Cancer Research and Treatment.
[57] Christine A Iacobuzio-Donahue,et al. Gene expression profiles associated with advanced pancreatic cancer. , 2008, International journal of clinical and experimental pathology.
[58] P. Russell,et al. The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer , 2013, Thorax.
[59] Peng Li,et al. Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review. , 2014, International journal of clinical and experimental pathology.
[60] Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization , 2015, Molecular Cancer.
[61] T. Ganesan,et al. Cancer Stem Cells - Are Surface Markers Alone Sufficient? , 2016, Current stem cell research & therapy.
[62] W. Shen,et al. SCD1 negatively regulates autophagy-induced cell death in human hepatocellular carcinoma through inactivation of the AMPK signaling pathway. , 2015, Cancer letters.
[63] D. Hess,et al. Inhibition of StearoylCoA Desaturase Activity Blocks Cell Cycle Progression and Induces Programmed Cell Death in Lung Cancer Cells , 2010, PloS one.
[64] J. Bellenger,et al. Inhibition of Stearoyl-CoA Desaturase 1 Expression Induces CHOP-Dependent Cell Death in Human Cancer Cells , 2010, PloS one.
[65] Yuhchyau Chen,et al. Cisplatin treatment increases stemness through upregulation of hypoxia‐inducible factors by interleukin‐6 in non‐small cell lung cancer , 2016, Cancer science.
[66] Michael F Clarke,et al. The biology of cancer stem cells. , 2007, Annual review of cell and developmental biology.
[67] B. Wang,et al. SCD1 Inhibition Causes Cancer Cell Death by Depleting Mono-Unsaturated Fatty Acids , 2012, PloS one.
[68] D. Ettinger,et al. Multidisciplinary management of lung cancer. , 2004, The New England journal of medicine.
[69] R. A. Igal,et al. Stearoyl CoA desaturase-1: New insights into a central regulator of cancer metabolism. , 2016, Biochimica et biophysica acta.